FDA Law Weekly

City College of New York - Spectral and temporal near-infrared imaging is developed for ex vivo breast cancer detection

Cognigen Corporation - Tigecycline has favorable pharmacokinetic profile in early animal studies

College of Allergy, Asthma and Immunology - Survey suggests many asthma-related ED visits could be prevented

Colorado State University - False positive S. zooepidemicus resistance related to inadequate quality control

Columbia University, New York - Platelet-derived growth factor inhibitors show promise for treatment

Corcept Therapeutics, Inc. - Corlux maker reports third-quarter net loss of $5.2 million, or $0.23 per share

Duke University, Durham - Glucose-regulated protein expression enhances cancer radiation therapy

DxS Ltd - Personalized medicine company launches consultancy and training service

Elan Pharmaceuticals - Beta-amyloid immunotherapy prevents synaptic degeneration

Erasmus Medical Center, Rotterdam - Risk score predicts death, MI, and stroke in stable angina patients

Errikos Dunant Hospital, Athens - Irinotecan and docetaxel therapy found effective in pre-treated metastatic breast cancer patients

Eyetech Pharmaceuticals, Inc. - Macugen maker reports third-quarter 2005 financial results: net income $2.8M

Faculty of Pharmacy Montpellier - Combined effects evident in melanoma drug resistance

Federal University of Santa Catarina - Seaweed derivative has antiangiogenic and antitumoral properties

Forschungsinstitut fur Molekulare Pharmakologie, Berlin - Recent findings illuminate research in antimicrobials

Fundacio Hospital Asil Granollers, Barcelona - Hyperlactatemia and lactic acidosis successfully treated in HIV patients taking NRTIs

Fundacion para el Estudio de las Hepatitis Virales, Madrid - Percentage of hepatitis C virus-infected hepatocytes is good response predictor

German Cancer Research Center, Heidelberg - Xanthohumol is a broad-spectrum anti-infective agent

GlaxoSmithKline - Mechanism of fluoroquinolone resistance development and spread are examined

Kansas State University - Professor's research could identify the face of terrorism

NeoRx Corporation - U.S. FDA grants orphan drug designation to picoplatin for small cell lung cancer

Roche Pharma - U.S. FDA approves erlotinib plus gemcitabine chemo for advanced pancreatic cancer

Shire Pharmaceuticals Inc. - Six-month study data find carbamazepine reduced manic and mixed symptoms in bipolar disorder

SimmonsCooper LLC - Law firm pledges $10.2 million for new cancer institute at Southern Illinois

Small Bone Innovations, LLC - Multi-use modular hand fixation system launched at hand surgery convention

Staar Surgical Company - Ophthalmic products developer reports decrease in third quarter net sales

TMF Health Quality Institute - Health quality company awarded Beneficiary Protection Program contract by CMS

Teva Pharmaceutical Industries Ltd. - U.S. FDA grants approval of generics for type 2 diabetes

U.S. Food & Drug Administration - Antimicrobial resistance is common in Shiga toxin-producing E. coli

U.S. Food & Drug Administration - Method to determine 112 halogenated pesticides using GC/MS is developed

University Hospitals of Cleveland - U.S. FDA approves safety test of adult stem cells in patients with heart disease

University of Queensland - TertaQ and pharmaceutical company form strategic plan to accelerate Australian drug development

University of Toronto - CD8 cell presence in semen does not correlate with levels of HIV-1 RNA shedding

University of Washington - Black-white disparity in receipt of recommended colon cancer treatment observed

University of Zurich Hospital - Studies describe new findings in diagnostics research